Offermans, Kelly http://orcid.org/0000-0001-6842-4887
Jenniskens, Josien C. A. http://orcid.org/0000-0003-2727-2981
Simons, Colinda C. J. M. http://orcid.org/0000-0002-0085-5186
Samarska, Iryna http://orcid.org/0000-0003-4092-0672
Fazzi, Gregorio E. http://orcid.org/0000-0001-7068-8435
Smits, Kim M. http://orcid.org/0000-0002-4629-4396
Schouten, Leo J. http://orcid.org/0000-0003-3361-7560
Weijenberg, Matty P. http://orcid.org/0000-0003-1695-4768
Grabsch, Heike I. http://orcid.org/0000-0001-9520-6228
van den Brandt, Piet A. http://orcid.org/0000-0001-8781-8099
Funding for this research was provided by:
KWF Kankerbestrijding (11044, 11044, 11044, 11044)
Article History
Received: 9 December 2022
Accepted: 8 January 2023
First Online: 1 February 2023
Declarations
:
: HG has received honoraria from Astra Zeneca and BMS for scientific advisory board activities not related to the current study. The remaining authors have no conflicts of interest to declare.
: The NLCS was approved by institutional review boards from Maastricht University and the Netherlands Organization for Applied Scientific Research. Ethical approval was obtained from Medical Ethical Committee of Maastricht University Medical Center + . By completing and returning the questionnaire, participants agreed to participate in the study.